WFMPM
EGRX

Woodley Farra Manion Portfolio Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Woodley Farra Manion Portfolio Management’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-300
Closed -$18K – 457
2019
Q4 		$18K Buy
+300
New +$17.9K ﹤0.01% 250

Other funds holding EGRX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Woodley Farra Manion Portfolio Management's EGRX Position: Q1 2020 in Review

Woodley Farra Manion Portfolio Management sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q1 2020, closing a stake of 300 shares — an estimated $18K sold.

Woodley Farra Manion Portfolio Management first reported a position in EGRX in Q4 2019 and held it in 1 quarter. The position peaked at $18K in Q4 2019. 168 funds tracked by Wall St. Rank hold EGRX as of Q1 2020.

  • Woodley Farra Manion Portfolio Management reported no remaining Eagle Pharmaceuticals, Inc. position as of Q1 2020 after selling out during the quarter.
  • Woodley Farra Manion Portfolio Management sold 300 Eagle Pharmaceuticals, Inc. shares in Q1 2020, an estimated $18K.
  • Woodley Farra Manion Portfolio Management first reported a position in Eagle Pharmaceuticals, Inc. in Q4 2019 and held it in 1 quarter.
  • Woodley Farra Manion Portfolio Management's Eagle Pharmaceuticals, Inc. position peaked at $18K in Q4 2019.
  • 168 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q1 2020.

Based on Woodley Farra Manion Portfolio Management's 13F filing for Q1 2020, filed 8 May 2020.